| Utomilumab | PF-05082566; PF-2566; PF-5082566 | Phase 3 Clinical | Pfizer Inc | Bone metastases; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Head and Neck Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Melanoma; Neoplasms; Oropharyngeal Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms | 詳細 |
| Urelumab | BMS-66513; BMS-663513 | Phase 2 Clinical | Bristol-Myers Squibb Company | Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colorectal Neoplasms; Glioblastoma; Gliosarcoma; Head and Neck Neoplasms; Leukemia; Leukemia, B-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Melanoma; Multiple Myeloma; Neoplasms; Skin Melanoma; Skin Neoplasms; Solid tumours; Urinary Bladder Neoplasms | 詳細 |
| ALG.APV-527 | ALG.APV 527; ADC-1016; ATOR-1016; ALG.APV-527; ALG-APV-527 | Phase 2 Clinical | Alligator Bioscience Ab, Aptevo Therapeutics Inc | | 詳細 |
| PE-0116 | PE-0116 | Phase 2 Clinical | Shanghai HyaMab Biotech Co Ltd | | 詳細 |
| Delolimogene mupadenorepvec | LOAd-703 | Phase 2 Clinical | Lokon Pharma, Uppsala University | Biliary Tract Neoplasms; Colorectal Neoplasms; Melanoma; Ovarian Neoplasms; Pancreatic Neoplasms | 詳細 |
| AGEN-2373 | AGEN-2373 | Phase 2 Clinical | Agenus Inc | Neoplasms; Pancreatic Neoplasms | 詳細 |
| ADG-106 | ADG106; ADG-106 | Phase 2 Clinical | Adagene (Suzhou) Ltd | Lymphoma, Non-Hodgkin; Solid tumours | 詳細 |
| Cinrebafusp alfa | PRS-343 | Phase 2 Clinical | Pieris Pharmaceuticals | Breast Neoplasms; Solid tumours; Stomach Neoplasms; Urinary Bladder Neoplasms | 詳細 |
| CTX-471 | CTX-471 | Phase 2 Clinical | Compass Therapeutics LLC | Carcinoma, Non-Small-Cell Lung; Glioblastoma; Head and Neck Neoplasms; Melanoma; Mesothelioma; Neoplasm Metastasis; Neoplasms; Small Cell Lung Carcinoma; Solid tumours | 詳細 |
| Tecaginlimab | BNT-312; GEN-1042 | Phase 2 Clinical | Genmab A/S | Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| AP-203 | AP-203; AP203 | Phase 2 Clinical | AP Biosciences Inc | Carcinoma, Non-Small-Cell Lung; Esophageal Squamous Cell Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| BOS-342 | PRS-342; BOS-342; PRS-342/BOS-342 | Phase 2 Clinical | Pieris Pharmaceuticals | Carcinoma, Hepatocellular; Solid tumours | 詳細 |
| ABL-104 | ABL-104; YH-32364 | Phase 2 Clinical | Abl Bio Inc | Colorectal Neoplasms; Head and Neck Neoplasms; Solid tumours | 詳細 |
| ABL-103 | ABL-103 | Phase 2 Clinical | Abl Bio Inc, Handok Inc | | 詳細 |
| Nesfrotamig | ABL105; YH-32367 | Phase 2 Clinical | Abl Bio Inc | Breast Neoplasms; Solid tumours; Stomach Neoplasms | 詳細 |
| BT-7480 | BT-7480 | Phase 2 Clinical | Bicycle Therapeutics | | 詳細 |
| BAT-7111 | BAT7111; BAT-7111 | Phase 2 Clinical | Bio-Thera Solutions Ltd | | 詳細 |
| Exlinkibart | LVGN-6051 | Phase 2 Clinical | Lyvgen Biopharma(HK)Ltd | Carcinoma, Hepatocellular; Esophageal Neoplasms; Head and Neck Neoplasms; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Papillomavirus Infections; Sarcoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Uveal melanoma | 詳細 |
| LM-2417 | LM-2417; LM2417 | Phase 2 Clinical | LaNova Medicines Ltd | | 詳細 |
| DSP-107 | KAHR-107; DSP-107 | Phase 2 Clinical | Kahr Medical | Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Solid tumours | 詳細 |
| DuoBody-EpCAMx4-1BB | BNT314/GEN1059; GEN-1059; GEN1059; BNT314 | Phase 2 Clinical | Biontech Se, Genmab A/S | Colorectal Neoplasms; Neoplasms; Solid tumours | 詳細 |
| LM-24C5 | LM-24C5 | Phase 2 Clinical | LaNova Medicines Ltd | | 詳細 |
| IBD-0333 | IBD-0333; IBD0333 | Phase 2 Clinical | SunHo (China) BioPharmaceutical Co Ltd | Lymphoma, Non-Hodgkin; Neoplasms; Solid tumours | 詳細 |
| PRS-344 | PRS-344S095012; S-095012; S-95012; PRS-344/ONC0055; PRS-344; PRS-344/S095012 | Phase 2 Clinical | Pieris Pharmaceuticals Inc | | 詳細 |
| HK-010 | HK-010; HK010 | Phase 2 Clinical | Anhui Anke Biotechnology (Group) Co Ltd, Hefei Hankemab Biotechnology Co Ltd | | 詳細 |
| Emfizatamab | GNC-038 | Phase 2 Clinical | Sichuan Baili Pharmaceutical Co Ltd, SystImmune | Arthritis, Rheumatoid; Central Nervous System Lymphoma; Lupus Erythematosus, Systemic; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Solid tumours | 詳細 |
| ARI-0002h | ARI-0002h | Phase 2 Clinical | Instituto De Salud Carlos Iii | | 詳細 |
| PM-1032 | PM1032; PM-1032 | Phase 2 Clinical | Shanghai Genechem Co Ltd | Neoplasms; Pancreatic Neoplasms | 詳細 |
| Englumafusp alfa | RG-6076; RO-7227166 | Phase 2 Clinical | F. Hoffmann-La Roche Ltd | Lymphoma, B-Cell; Lymphoma, Non-Hodgkin | 詳細 |
| Opamtistomig | LBL-024; LBL024 | Phase 2 Clinical | Nanjing Leadsbiolabs Co Ltd | Carcinoma, Neuroendocrine; Melanoma; Neoplasms; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| QLF31907 | QLF31907; QLF-31907 | Phase 2 Clinical | Qilu Pharmaceutical Co Ltd | Carcinoma, Transitional Cell; Lymphoma, Non-Hodgkin; Melanoma; Neoplasms; Solid tumours | 詳細 |
| EU-101 | EU-101; NOV-1801 | Phase 2 Clinical | Eutilex | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Prostatic Neoplasms; Solid tumours | 詳細 |
| Nebratamig | GNC-035 | Phase 2 Clinical | Sichuan Baili Pharmaceutical Co Ltd | Breast Neoplasms; Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Metastatic breast cancer; Solid tumours | 詳細 |
| Givastomig | TJ-CD4B; ABL-111; TJ-CLDN4B; TJ-033721; TJ-CD4B/ABL111 | Phase 2 Clinical | I-Mab Biopharma Co Ltd | Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Neoplasm Metastasis; Neoplasms; Solid tumours; Stomach Neoplasms | 詳細 |
| Prizloncabtagene autoleucel | JNJ-4496; EXP-039; C-CAR039; C-CAR-039; C CAR 039; EXP0-039; JNJ-90014496 | Phase 2 Clinical | Cellular Biomedicine Group Ltd | Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin | 詳細 |
| PM-1003 | PM1003 | Phase 2 Clinical | | | 詳細 |
| FS-120 | FS-120 | Phase 1 Clinical | F-Star | Neoplasm Metastasis; Neoplasms | 詳細 |
| MCLA-145 | MCLA-145 | Phase 1 Clinical | Incyte Corp, Merus Nv | Lymphoma, B-Cell; Neoplasms; Solid tumours | 詳細 |
| CD137/FAP bispecific agonist antibody (Boehringer Ingelheim International) | | Phase 1 Clinical | Boehringer Ingelheim International Gmbh | | 詳細 |
| AP-601 | AP-601 | Phase 1 Clinical | AP Biosciences Inc | | 詳細 |
| BH-3120 | BH-3120 | Phase 1 Clinical | Hanmi Pharmaceutical Co Ltd | | 詳細 |
| Xirestomig | ATG-101; ATG101; YN051 | Phase 1 Clinical | The Origin Cell Technology Group Co Ltd | Hematologic Neoplasms; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Solid tumours | 詳細 |
| QL-301 | QL-301 | Phase 1 Clinical | Qlsf Biotherapeutics Inc | | 詳細 |
| MP-0310 | MP-0310; AMG-506 | Phase 1 Clinical | Amgen Inc, Molecular Partners Ag | | 詳細 |
| YH-004(Hangzhou Yuhong Medical Tech) | YH-004 | Phase 1 Clinical | Hangzhou Yuhong Medical Technology Co Ltd | | 詳細 |
| hTERT-induced natural T cells therapy(Eutilex) | | Phase 1 Clinical | Eutilex | | 詳細 |
| BGB-B2033 | BGB-B-2033; BGB-B2033 | Phase 1 Clinical | Beigene Guangzhou Biologics Manufacturing Co Ltd | Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Neoplasms; Solid tumours; Stomach Neoplasms | 詳細 |
| BHP-01 | BHP-01; BHP01; α-PD-L1/4-1BB DLL3 CAR-T | Phase 1 Clinical | Chengdu Brilliant Pharmaceutical Co Ltd | Small Cell Lung Carcinoma | 詳細 |
| ND-021 | ND-021; NM21-1480; CS-2006; CS2006 | Phase 1 Clinical | Cstone Pharmaceuticals, Numab Therapeutics Ag | Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Squamous Cell; Colorectal Neoplasms; Fallopian Tube Neoplasms; Neoplasms; Peritoneal Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms | 詳細 |
| FTL-008.16 | FTL-008.16; FTL008.16 | Phase 1 Clinical | Sound(Chengdu)Biopharmacauticals Co Ltd | | 詳細 |
| NBL-028 | NBL028; NBL-028 | Phase 1 Clinical | Novarock Biotherapeutics Ltd, Shanghai Xinshi Biological Medicine Co Ltd | Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms; Testicular Neoplasms | 詳細 |
| SAIL-66 | SAIL66; SAIL-66 | Phase 1 Clinical | Chugai Pharmaceutical Co Ltd | | 詳細 |
| BC 3425 | BC-3425 | Phase 1 Clinical | Wuxi BioCity | | 詳細 |
| ASP1002 | ASP-1002; ASP1002 | Phase 1 Clinical | Astellas Pharma Global Development Inc | | 詳細 |
| RG-6524 | RO-7616789; ALPS-12; RG6524 | Phase 1 Clinical | F. Hoffmann-La Roche Ag | Carcinoma, Neuroendocrine; Small Cell Lung Carcinoma | 詳細 |
| SGN-BB228 | SGN-BB228; PF-08046049; BB-228; PRS-346 | Phase 1 Clinical | Pieris Pharmaceuticals | Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Mesothelioma; Pancreatic Neoplasms; Skin Melanoma; Solid tumours | 詳細 |
| Ori-Bs-001 | Ori-Bs-001 | Phase 1 Clinical | OriCell Therapeutics Co Ltd | | 詳細 |
| IMB-071703 | IMB-071703; IMB071703 | Phase 1 Clinical | Beijng Immunoah Pharma Tech Co Ltd | | 詳細 |
| ADG-206 | ADG-206 | Phase 1 Clinical | Adagene (Suzhou) Ltd | | 詳細 |
| TJ-C64B | TJ-C64B | Phase 1 Clinical | I-Mab Biopharma Co Ltd | Ovarian Neoplasms; Stomach Neoplasms | 詳細 |
| ZG-033 | ZG033; HK-003 | Phase 1 Clinical | Hefei Hankemab Biotechnology Co Ltd | | 詳細 |
| STA-551 | STA-551 | Phase 1 Clinical | Chugai Pharmaceutical Co Ltd | | 詳細 |
| FS222 mAb² (F-star Therapeutics) | FS-222 | Phase 1 Clinical | F-star Beta Ltd | Neoplasm Metastasis; Neoplasms; Solid tumours | 詳細 |
| FTL-001 | FTL001; FTL-001 | Phase 1 Clinical | Sound(Chengdu)Biopharmacauticals Co Ltd, Xikang (Wuhan) Biomedicine Co Ltd | | 詳細 |
| BI-765179 | BI-765179 | Phase 1 Clinical | Boehringer Ingelheim International Gmbh | Neoplasms; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| DF-003(Dingfu Biotarget) | DF-003 | Phase 1 Clinical | Dingfu Biotarget Co Ltd | Lymphoma, Non-Hodgkin; Solid tumours | 詳細 |
| CB-307 | CB-307; CB307 | Phase 1 Clinical | Crescendo Bioscience Inc | Neoplasms; Prostatic Neoplasms, Castration-Resistant | 詳細 |
| RO-7122290 | RO-7122290; RG-7827 | Phase 1 Clinical | F. Hoffmann-La Roche Ltd | | 詳細 |
| Ragistomig | ABL-503; TJ-L14B/ABL503; ABL503; TJ-L14B | Phase 1 Clinical | I-Mab Biopharma Co Ltd | | 詳細 |
| HLX-35 | HLX-35; BNA035 | Phase 1 Clinical | | Carcinoma, Non-Small-Cell Lung; Solid tumours | 詳細 |
| GNC-039 | GNC-039 | Phase 1 Clinical | Sichuan Baili Pharmaceutical Co Ltd | Glioma; Hematologic Neoplasms; Neoplasm Metastasis; Solid tumours | 詳細 |
| HBM-7008 | HBM7008; HBM-7008; R-7008; CLN-418 | Phase 1 Clinical | Harbour Biomed | | 詳細 |
| IBI-319 | IBI-319 | Phase 1 Clinical | | | 詳細 |
| YH-004 | YH-004 | Phase 1 Clinical | | Lymphoma, Non-Hodgkin; Neoplasms; Solid tumours | 詳細 |
| HOT-1030 | HOT-1030 | Phase 1 Clinical | HuaBo Biopharm Co Ltd | | 詳細 |
| QL-1806 | QL-1806 | Phase 1 Clinical | Qilu Pharmaceutical Co Ltd | | 詳細 |
| Cedarizumab | | Phase 1 Clinical | Therawisdom Biopharma Co Ltd | Carcinoma, Transitional Cell; Melanoma; Solid tumours | 詳細 |
| Evunzekibart | ATOR-1017 | Phase 1 Clinical | Alligator Bioscience Ab | | 詳細 |